The Red Cells in Hemolytic Disease of the Newborn*

2015 ◽  
pp. 370-374
Author(s):  
T. J. Greenwalt
Keyword(s):  
PEDIATRICS ◽  
1955 ◽  
Vol 15 (1) ◽  
pp. 54-62
Author(s):  
Clare N. Shumway ◽  
Gerald Miller ◽  
Lawrence E. Young

Ten infants with hemolytic disease of the newborn due to ABO incompatibility were studied. In every case the investigations were undertaken because of jaundice occurring in the first 24 hours of life. The clinical, hematologic and serologic observations in the infants and the serologic findings in the maternal sera are described. Evidence is presented to show that the diagnosis of the disorder rests largely upon the demonstration of spherocytosis, increased osmotic fragility of the red cells, reticulocytosis, and hyperbilirubinemia in a newborn infant whose red blood cells are incompatible with the maternal major blood group isoantibody and against whose cells no other maternal isoantibody is demonstrable. The anti-A or anti-B in each of the maternal sera tested in this series hemolyzed A or B cells in the presence of complement. Other serologic findings in the maternal sera were less consistently demonstrated.


Blood ◽  
1953 ◽  
Vol 8 (7) ◽  
pp. 620-639 ◽  
Author(s):  
HAL CRAWFORD ◽  
MARIE CUTBUSH ◽  
P. L. MOLLISON

Abstract Eleven cases of hemolytic disease of the newborn are described in which the only blood group antibody in the mother's serum, incompatible with the infant's cells, was anti-A. The direct antiglobulin (Coombs) test on the infant's red cells was weakly positive in 7 cases and negative in 4 cases. In every case the mother's serum displayed immune characteristics, in particular the ability to lyse A cells. Osmotic fragility was increased in 10 out of 11 cases. This finding is contrasted with those in a series of cases of hemolytic disease of the newborn due to anti-Rh.


PEDIATRICS ◽  
1972 ◽  
Vol 50 (1) ◽  
pp. 169-169
Author(s):  
Jane Desforges

In hemolytic disease, it is always difficult to comment on the properties of red cells which have already been removed from the circulation. One can only study those left behind and presumably, therefore, less injured. However, with the mechanism of immunohemolysis in Rh incompatibility as a prototype, one can propose hemolytic disease of the newborn in ABO incompatibility to be related to a coating antibody which is not complement dependent, rather than to the hemolysin.


PEDIATRICS ◽  
1972 ◽  
Vol 50 (1) ◽  
pp. 169-169
Author(s):  
B. D. Gordon

The article by Drs. Wang and Desforges indicated that complement was not involved in ABO hemolytic disease because they could not detect it on red cells in such cases. In 1964, Dr. Gordon Archer of the Red Cross Blood Transfusion Service, Sydney, reported to the Second Annual Meeting of the Australian Society of Immunologists that red cells coated with anti-A or anti-B antibodies set up a strong chemotactic effect on polymorpho-nuclear leukocytes, predominantly neutrophils and eosinophils.


Blood ◽  
1954 ◽  
Vol 9 (2) ◽  
pp. 103-116 ◽  
Author(s):  
WILLIAM H. CROSBY ◽  
JOSEPH H. AKEROYD

Abstract 1. Following large transfusions of low titer group O blood into patients of group A, B, and AB it was not possible to demonstrate foreign isohemolysins or incomplete antibodies in the serum of recipients. Cold isoagglutinins were frequently demonstrated immediately after the transfusion, but they usually disappeared rapidly. Its several patients the titer of foreign anti-A isoagglutinin was quite high and the antibody persisted in the circulation for several days. It was suggested that the persistence of these agglutinins may have been possible because there was a relatively small amount of A substance in the body of the recipient. Where the transfused isoagglutinins persisted the patients were found to be nonsecretors or weak secretors of A substance in the saliva. 2. In most of these patients there was evidence of a selective destruction of recipient red cells after the transfusion of O blood. This was probably due to the activity of transfused isoantibodies in the plasma of the O blood. This hemolytic activity was observed where it was not possible to demonstrate the presence of foreign isoantibodies. It is suggested that there may exist forms of antibody that cannot be demonstrated by laboratory methods. These antibodies manifest themselves only by causing destruction of red cells in vivo. 3. Clinically the hemolytic disease on the basis of such transfused isoantibodies while causing destruction of native red cells did not threaten the lives or impede the recovery of these patients. No reactions were encountered and none were heard of in Korea that might have been ascribed to a dangerous universal donor. The partition of group O blood into high titer and low titer on the basis of dilution of 1:200 to 1:256 has proved in practice to be safe. 4. The persistence of foreign antibodies after a large transfusion of group O blood may make it impossible to cross match the patient’s blood with blood of his hereditary group. Severe transfusion reactions have occurred when group specific blood has been given following large transfusions of group O blood. It has been recommended that after a large transfusion of group O blood has been given, group specific blood should not be used for at least two weeks.


PEDIATRICS ◽  
1971 ◽  
Vol 48 (4) ◽  
pp. 650-653
Author(s):  
May Y. F. W. Wang ◽  
Jane F. Desforges

Complement titres were measured in three groups of newborn infants from group O mothers: I. 31 group O infants. II. 10 group A or B infants with probable ABO hemolytic disease of the newborn (ABO HDN). III. 18 group A or B infants without ABO HDN. Seven of the Group II infants had positive direct Coombs' test, and one of these required exchange transfusion; the three babies with negative direct Coombs' test had clinical course compatible with ABO HDN. There was no significant difference in the complement titres among these various groups. Anti-serum to human C3 and C4 was used to detect complement components on the fetal red cells of 4 infants in Group I, 5 infants in Group II, and eight infants in Group III. The reaction was negative in all these cases. These results suggest that complement does not participate in the in vivo destruction of red cells in cases of hemolytic disease of newborn infants due to ABO incompatibility.


Blood ◽  
1954 ◽  
Vol 9 (8) ◽  
pp. 749-772 ◽  
Author(s):  
ARNO G. MOTULSKY ◽  
WILLIAM H. CROSBY ◽  
HENRY RAPPAPORT

Abstract Extensive studies were performed on four cases from three unrelated kindreds with a familial hemolytic syndrome not associated with any significant red cell anomaly (hereditary nonspherocytic hemolytic disease). These cases were compared with similar ones already reported in the literature. 1. Hereditary nonspherocytic hemolytic disease appears to be transmitted as a Mendelian dominant. Frequently the gene responsible for the condition seems to have low expressivity. In some cases, the hereditary mechanism may be due to inheritance of a recessive gene from each parent. The basic erythrocytic defect responsible for the condition is unknown. In view of various clinical and hematologic findings, it is likely that hereditary nonspherocytic hemolytic disease may be a group of diseases involving more than one mechanism. 2. All criteria of hemolytic anemia (erythroid hyperplasia of the bone marrow, reticulocytosis, hyperbilirubinemia, increased fecal urobilinogen, rapid turnover of tracer iron in the plasma) were satisfied. 3. Red cell survival time studies revealed an intraerythrocytic defect with a mean life span of twelve to seventeen days. Normal red cells transfused into the patients under study survived normally. Anemia was normochromic and normocytic or macrocytic; it varied from mild to severe. 4. Osmotic and mechanical fragility of the red cells was normal. Osmotic and mechanical fragility tests after incubation at 37 C. for 24 hours in some showed a mild increase compared with normal controls. Autohemolysis of incubated oxalated blood was not marked and varied from case to case. 5. The electrophoretic mobility of hemoglobin from the patients was that of normal adult hemoglobin. Small increases of fetal hemoglobin were seen in several cases. 6. In contrast to the histologic findings in hereditary spherocytosis the splenic pulp was not congested, but hemosiderin deposits were heavy. Liver biopsy specimens showed deposits of hemosiderin in parenchymal and Kupffer cells. 7. Splenectomy did not arrest the hemolytic process. Mild improvement was seen in one case. In most cases the operation is of no value. 8. Diagnostic difficulties may be encountered with mild cases of hereditary spherocytosis. Examination of rouleaux in fresh blood and an osmotic fragility test in 0.65 per cent sodium chloride after incubation usually establishes the differential diagnosis. The condition may present clinically as hemolytic disease of the newborn and must be differentiated from erythroblastosis due to Rh or other blood group incompatibilities. Other hereditary hemolytic diseases such as sickle cell anemia, Cooley’s anemia, hereditary spherocytosis, and hereditary hemolytic elliptocytosis are easily ruled out by their typical clinical and hematologic manifestations. When a family study is negative or cannot be done, a red cell survival time determination may be necessary to rule out acquired hemolytic anemia with a negative Coombs test. Some cases that have been diagnosed as constitutional hyperbilirubinemia (familial nonhemolytic jaundice) may actually represent mild hereditary nonspherocytic hemolytic disease.


Blood ◽  
1960 ◽  
Vol 15 (5) ◽  
pp. 662-674 ◽  
Author(s):  
WILLIAM H. CROSBY ◽  
MARCEL E. CONRAD

Abstract 1. Two healthy patients with hereditary spherocytosis were phlebotomized until they developed iron deficiency and the erythrocytes became hypochromic. The hereditary spherocytes were no longer spheroidal: they became thin, and the fragility tests improved. However, the life span of the cells in the circulation was not improved. Later, splenectomy corrected the hemolytic disease. 2. In both patients, prior to the experiment, the hemolytic disease was compensated. There was no anemia despite the rapid turnover of red cells. In one of the patients, whose average red cell life span was only five days, the output of hemoglobin must have been exceedingly high. It was computed to be 135 Gm. per day, or 20 times the normal rate. 3. Some aspects of iron metabolism in hereditary spherocytosis are discussed. 4. The shape of the red cell in HS does not appear to be responsible for its premature destruction by the spleen. Iron deficiency corrects the spherocytosis, but it does not correct the hemolytic disease. Splenectomy corrects the hemolytic disease, but it does not correct the spherocytosis.


Blood ◽  
1961 ◽  
Vol 18 (2) ◽  
pp. 220-224 ◽  
Author(s):  
WILLIAM H. CROSBY ◽  
CALOGERO VULLO ◽  
SERGIO GARRIGA

Abstract Autohemolysis occurs in vitro in the blood of some patients with leukemia and other disseminated neoplastic diseases. It is known that patients with such diseases are frequently anemic and hemolytic disease frequently contributes to the anemia. The present study has demonstrated that the in vitro autohemolytic phenomenon is not necessarily associated with a short red cell life span. This suggests that the abnormality does not damage the red cells while they are in the circulation.


Sign in / Sign up

Export Citation Format

Share Document